We’re just a week away from Seattle’s Life Science Disruptors—and we’re offering you the chance to save $80. It all takes place next Monday, May 2, at the Fred Hutchinson Cancer Research Center in Seattle, WA.
Join us to for fireside chats, spotlight talks, keynotes, and more with some of Seattle’s top entrepreneurs, investors, and leaders in the biotech and public health industry.
Our speakers include:
• David Baker, Head of the Institute for Protein Design, University of Washington
• Aaron Chevalier, CTO, Virvio
• Rhea Coler, SVP Preclinical and Translational Research, Infectious Disease Research Institute
• Larry Corey, Principal Investigator, HIV Vaccine Trials Network
• Jennifer Dent, President, BIO Ventures for Global Health
• John Fluke, Chairman, Fluke Capital Management
• Stephen Friend, President, Co-founder, & Director, Sage Bionetworks
• Rob Hershberg, CSO, Celgene
• Leen Kawas, CEO, M3 Biotechnology
• Thong Le, CEO, Accelerator
• Clayton Lewis, CEO, Arivale
• Molly Moore, Assistant Director, Direct Health Solutions Business Development, Cambia Health Solutions
• Lucas Nivon, CEO, Cyrus Biotechnology
• Nicole Robinson, VP of Industry Relations & Business Development, Fred Hutchinson Cancer Research Center
• Andrew Scharenberg, Principal Investigator, Seattle Children’s Research Institute
• Ingrid Swanson Pultz, President, PVP Biologics
• Jim Thomas, CEO, Just Biotherapeutics
• Matthew Trunnell, Chief Information Officer, Fred Hutchinson Cancer Research Center
• Cameron Turtle, Immunotherapy researcher and Oncologist, Fred Hutchinson Cancer Research Center
• Austin Walsh, Senior State Executive for Washington and Alaska, IBM
Take a look at our agenda to see the sessions and full speaker list. Also, don’t forget to register before midnight to save $80 on regular registration.